{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:44:39Z","timestamp":1771922679484,"version":"3.50.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Motor neuron diseases (MND) are progressively fatal diseases causing loss of motor neurons throughout the body. Recent studies have suggested an increase in prevalence and mortality of amyotrophic lateral sclerosis (ALS), the most common adult-onset MND. It is unclear whether the increase is because of earlier diagnosis or potentially new exposures. Age-period-cohort (APC) analysis can help identify contributors to temporal disease trends by differentiating impacts of biological aging, historical time period, and birth cohort. The aim of this study is to evaluate APC effects on MND mortality in the United States from 2001 to 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed deaths by MND for the period 2001\u20132020 in subjects aged 40\u201384\u202fyears. We used APC modeling to compute net drift, local drift, longitudinal age curve, rate ratios (RR), and confidence intervals (CI) for each period and cohort. Analysis used the APC Web Tool provided by the United States\u2019 National Cancer Institute.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Over the 20-year period, there were 119,890 MND deaths. Men consistently had higher mortality compared to women. Analysis yielded noteworthy birth cohort effects for men. For men, the cohort RR decreased from 1919 to 1953 and peaked again between 1959 and 1963. Men born after 1973 had a reduced RR\u202f=\u202f0.77 (95% CI\u202f=\u202f0.63\u20130.94). Women born after 1973 had a cohort RR\u202f=\u202f1.00 (95% CI\u202f=\u202f0.75\u20131.34).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>APC analysis revealed potentially impactful age, period, and cohort effects in U.S. MND mortality between 2001 and 2020, with higher mortality among men and evidence of sex-specific cohort patterns. Cohort effects suggest potential generational differences in risk. Further investigation is needed to disentangle ascertainment effects from true etiologic influences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1751690","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:35:35Z","timestamp":1768973735000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Age-period-cohort effect on motor neuron disease mortality in the United States, 2001\u20132020"],"prefix":"10.3389","volume":"16","author":[{"given":"Jaime","family":"Raymond","sequence":"first","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Larson","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Nair","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Kevin","family":"Horton","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Weisskopf","sequence":"additional","affiliation":[{"name":"Department of Environmental Health, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraya","family":"Mohidul","sequence":"additional","affiliation":[{"name":"Hite Consulting Inc.","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mehta","sequence":"additional","affiliation":[{"name":"Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry (ATSDR)\/Centers for Disease Control and Prevention (CDC)","place":["Atlanta, GA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000488891","article-title":"Amyotrophic lateral sclerosis mortality in the United States, 2011-2014","volume":"51","author":"Larson","year":"2018","journal-title":"Neuroepidemiology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1080\/21678421.2021.2023190","article-title":"Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016","volume":"23","author":"Mehta","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/21678421.2016.1195410","article-title":"Prognostic factors and survival of ALS patients from Belgrade, Serbia","volume":"17","author":"Stevic","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/aje\/kwt116","article-title":"Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970-2009","volume":"178","author":"Seals","year":"2013","journal-title":"Am J Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e0210574","DOI":"10.1371\/journal.pone.0210574","article-title":"Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: a population-based retrospective cohort study (2003-2014)","volume":"14","author":"Rose","year":"2019","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.mayocpiqo.2024.07.008","article-title":"Prognostic factors and epidemiology of amyotrophic lateral sclerosis in southeastern United States","volume":"8","author":"Engelberg-Cook","year":"2024","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/archneurol.2009.13","article-title":"Amyotrophic lateral sclerosis in Sweden, 1991-2005","volume":"66","author":"Fang","year":"2009","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000086679","article-title":"Amyotrophic lateral sclerosis mortality in the United States, 1979-2001","volume":"25","author":"Sejvar","year":"2005","journal-title":"Neuroepidemiology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000334632","article-title":"Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis","volume":"38","author":"Ajdacic-Gross","year":"2012","journal-title":"Neuroepidemiology"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","article-title":"Epidemiology of amyotrophic lateral sclerosis: an update of recent literature","volume":"32","author":"Longinetti","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1212\/01.WNL.0000156518.22559.7F","article-title":"Temporal and geographic variation in United States motor neuron disease mortality, 1969-1998","volume":"64","author":"Noonan","year":"2005","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1212\/WNL.55.9.1262","article-title":"Increasing mortality from amyotrophic lateral sclerosis in Norway?","volume":"55","author":"Seljeseth","year":"2000","journal-title":"Neurology"},{"key":"ref13","volume-title":"Amyotrophic lateral sclerosis","author":"Mitsumoto","year":"1998"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21678421.2023.2245858","article-title":"Prevalence of amyotrophic lateral sclerosis in the United States, 2018","volume":"24","author":"Mehta","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/mus.27450","article-title":"Demographics, clinical characteristics, and prognostic factors of amyotrophic lateral sclerosis in Midwest","volume":"65","author":"Yamakawa","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/21678421.2019.1612435","article-title":"Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) registry, 2010-2015","volume":"20","author":"Raymond","year":"2019","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jocn.2017.08.035","article-title":"Military service and the risk of amyotrophic lateral sclerosis: a meta-analysis","volume":"45","author":"Tai","year":"2017","journal-title":"J Clin Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/WCO.0b013e32832ffbe3","article-title":"Recent advances in motor neuron disease","volume":"22","author":"Van Damme","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/mus.880180711","article-title":"Amyotrophic lateral sclerosis is a multifactorial disease","volume":"18","author":"Eisen","year":"1995","journal-title":"Muscle Nerve"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1108383","DOI":"10.3389\/fneur.2023.1108383","article-title":"Urbanization, air pollution, and water pollution: identification of potential environmental risk factors associated with amyotrophic lateral sclerosis using systematic reviews","volume":"14","author":"Saucier","year":"2023","journal-title":"Front Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ncl.2015.07.009","article-title":"Potential environmental factors in amyotrophic lateral sclerosis","volume":"33","author":"Oskarsson","year":"2015","journal-title":"Neurol Clin"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/21678421.2022.2127324","article-title":"Occupational history associates with ALS survival and onset segment","volume":"24","author":"Goutman","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/21678421.2024.2358786","article-title":"Prevalence of ALS in all 50 states in the United States, data from the national ALS registry, 2011-2018","volume":"25","author":"Mehta","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref24","article-title":"Authority for congressional ALS registry: Centers for Disease Control and Prevention","year":"2017"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/sim.4780060405","article-title":"Models for temporal variation in cancer rates. I: age-period and age-cohort models","volume":"6","author":"Clayton","year":"1987","journal-title":"Stat Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/sim.4780060406","article-title":"Models for temporal variation in cancer rates. II: age-period-cohort models","volume":"6","author":"Clayton","year":"1987","journal-title":"Stat Med"},{"key":"ref27","article-title":"Mortality 1999\u20132020 on CDC WONDER Online Database. Data are from the Multiple Cause of Death Files, 1999\u20132020, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program 2021","year":"2020"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/03014460.2019.1707872","article-title":"Age period cohort analysis: a review of what we should and shouldn't do","volume":"47","author":"Bell","year":"2020","journal-title":"Ann Hum Biol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00415-016-8215-z","article-title":"Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence","volume":"263","author":"Tobin","year":"2016","journal-title":"J Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e209391","DOI":"10.1212\/WNL.0000000000209391","article-title":"Irish amyotrophic lateral sclerosis incidence: age, period, and cohort effects using a partial least squares regression model","volume":"102","author":"McFarlane","year":"2024","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1007\/s00415-016-8273-2","article-title":"Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study","volume":"263","author":"Nakken","year":"2016","journal-title":"J Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/acn3.51762","article-title":"Causes of death among United States decedents with ALS: an eye toward delaying mortality","volume":"10","author":"Larson","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/21678421.2016.1195409","article-title":"Motor neuron disease mortality rates in U.S. states are associated with well water use","volume":"17","author":"Schwartz","year":"2016","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/21678421.2013.787629","article-title":"Amyotrophic lateral sclerosis\/motor neuron disease deaths in the United States, 1999-2009","volume":"14","author":"Mehal","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10654-011-9595-0","article-title":"Changing mortality for motor neuron disease in France (1968-2007): an age-period-cohort analysis","volume":"26","author":"Gordon","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fneur.2019.00754","article-title":"Hypothesis: etiologic and molecular mechanistic leads for sporadic neurodegenerative diseases based on experience with Western Pacific ALS\/PDC","volume":"10","author":"Spencer","year":"2019","journal-title":"Front Neurol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/21678421.2021.1936556","article-title":"Case-control study in ALS using the national ALS registry: lead and agricultural chemicals are potential risk factors","volume":"23","author":"Mitsumoto","year":"2022","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17482960902721634","article-title":"ALS in Italian professional soccer players: the risk is still present and could be soccer-specific","volume":"10","author":"Chio","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/21678421.2021.1910308","article-title":"History of vigorous leisure-time physical activity and early onset amyotrophic lateral sclerosis (ALS), data from the national ALS registry: 2010-2018","volume":"22","author":"Raymond","year":"2021","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1212\/01.WNL.0000148649.17706.D9","article-title":"Prospective study of military service and mortality from ALS","volume":"64","author":"Weisskopf","year":"2005","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/21678421.2023.2189911","article-title":"Association of the practice of contact sports with the development of amyotrophic lateral sclerosis","volume":"24","author":"Henriques","year":"2023","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"ref43","first-page":"605","article-title":"Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data","volume-title":"Nat Comput Sci","author":"Ramamoorthy","year":"2022"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","article-title":"Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis","volume":"21","author":"Goutman","year":"2022","journal-title":"Lancet Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3109\/21678421.2014.984725","article-title":"The ALS ice bucket challenge - can a splash of water reinvigorate a field?","volume":"15","author":"Wicks","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2147\/JMDH.S134992","article-title":"Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach","volume":"10","author":"Hogden","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/21678421.2024.2401621","article-title":"Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional study","volume":"26","author":"Raymond","year":"2024","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3310\/nihropenres.13786.2","article-title":"Demographic trends of motor neurone disease-associated mortality from 1999-2020 in the United States","volume":"4","author":"Imantalab D","year":"2025","journal-title":"NIHR Open Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e1227","DOI":"10.1212\/WNL.0000000000011467","article-title":"Incidence, prevalence, and geographical clustering of motor neuron disease in the Netherlands","volume":"96","author":"de Jongh","year":"2021","journal-title":"Neurology"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1136\/jech.46.5.517","article-title":"Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis","volume":"46","author":"Chio","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/17482968.2011.614253","article-title":"Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS surveillance pilot project","volume":"13","author":"Stickler","year":"2012","journal-title":"Amyotroph Lateral Scler"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1751690\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:39:31Z","timestamp":1771918771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1751690\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":51,"alternative-id":["10.3389\/fneur.2025.1751690"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1751690","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1751690"}}